Risk prediction model for overall survival in lung cancer based on inflammatory and nutritional markers
Authors:
Open Access
- 22 August 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Abstract
This study aims to develop a multidimensional risk prediction model, identify characteristic inflammation-nutrition biomarkers, and optimize clinical decision-making. The study included 500 lung cancer patients diagnosed between October 2019 and October 2024 at a tertiary medical institution in Guiyang, China. The exposure variables included eight inflammation-nutrition biomarkers: neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), hemoglobin-albumin-lymphocyte-platelet score (HALP), prognostic nutritional index (PNI), hemoglobin-to-red cell distribution width ratio (HRR), and albumin-to-globulin ratio (ALB/GLB). The outcome variable was overall survival (OS). This study aimed to predict 1-year mortality rather than conduct traditional time-to-event survival analysis. All patients were followed until death or a uniform administrative censoring point.LASSO logistic regression was employed to model the outcome as a binary classification (death within 1 year: yes/no).This study employed a small-sample modeling approach, initially using LASSO regression for feature selection and dimensionality reduction, followed by variance inflation factor and collinearity screening for secondary feature selection. Finally, the Support Vector Machine-Recursive Feature Elimination (SVM-RFE) algorithm was used to optimize feature variables. The results showed that age, clinical stage, poor differentiation, ECOG PS 0–1, serum albumin level, LMR, HRR, and ALB/GLB were independent prognostic factors. Based on these factors, a lung cancer mortality risk prediction model was developed, and a corresponding web-based calculator was created, providing a practical tool to support clinical decision-making and personalized treatment strategies.Keywords
Funding Information
- Inner Mongolia Autonomous Region Natural Science Fund (2022LHQN07001, 2024QN07005)
This publication has 14 references indexed in Scilit:
- Prognostic significance of hemoglobin, albumin, lymphocyte and platelet score in solid tumors: a pooled studyFrontiers in Immunology, 2024
- Optimizing Care Across the Continuum for Older Adults with Lung Cancer: A ReviewCancers, 2024
- Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centersBMC Medicine, 2024
- Older adults with cancer and common comorbidities—challenges and opportunities in improving their cancer treatment outcomesJNCI: Journal of the National Cancer Institute, 2024
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2024
- The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancerScientific Reports, 2024
- Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung CancerMedical Principles and Practice, 2023
- Systemic Inflammation and Lung Cancer: Is It a Real Paradigm? Prognostic Value of Inflammatory Indexes in Patients with Resected Non-Small-Cell Lung CancerCancers, 2023
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- How to develop a more accurate risk prediction model when there are few eventsBMJ, 2016